2022 Abstracts

Poster 3: Routinizing Bacterial STI Screening and Testing in Three High Incidence Jurisdictions of the US

Poster 4: Early Real-World Use of Long-Acting Cabotegravir + Rilpivirine in the US

Poster 6: Lenacapavir as Part of a Combination Regimen in Treatment-naïve People with HIV: Week 54 Results

Poster 7: Long-Acting Lenacapavir in People With Multidrug-Resistant HIV-1: Week 52 Results

Poster 8: Association Between Weight Gain and the Incidence of Cardiometabolic Conditions Among People Living With HIV-1 at High Risk of Weight Gain Initiated on Antiretroviral Therapy

Poster 9: B/F/TAF Five-Year Outcomes in Treatment-Naïve Adults

Poster 10: Improving the success rate of anal pap smears among people living with HIV: a quality improvement project

Poster 13: Insufficient PrEParation: An Assessment of the Use of and Adherence to Preexposure Prophylaxis in Patients at Risk of HIV Acquisition at an Academic Medical Center

Poster 14: nvestigating HIV Viral Suppression Rates at Varying Proportion of Days Covered Ranges within a Medical Home Model

Poster 15: Predictors of Incident HIV-Associated Wasting and Low Wei9ght in the Opera Cohort

Poster 16: Discordance in care of common comorbidities in people living with HIV using real world data

Poster 17: ACUTE HIV SEROCONVERSION WITH PNEUMOCYSTIS JIROVECII PNEUMONIA IN A MALE WITH HIGH-RISK SEXUAL BEHAVIORS

Abstract 19:CASE: Switch to Ibalizumab in Suppressed Person with HIV with Immunosuppressive Drug-Drug Interactions After Liver Transplant

Poster 20: Hepatitis C Treatment through Mobile Clinic Encourages HIV Care Engagement

Poster 22: Case: Successful Viral Suppression Using a Fully Injectable ART Combination Therapy of Ibalizumab + Cabotegravir/Rilpivirine in an HIV+ Patient with Malabsorption

Poster 23: Adherence to cirrhosis care after hepatitis C sustained virologic response (SVR) in Veterans living with and without HIV

Poster 27: A Daily Single-Tablet Regimen of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed Adults Living With HIV and End-stage Renal Disease on Chronic Hemodialysis

Poster 29: Penn Community Practice: Cabotegravir/Rilpivirine Workflow

Poster 30: Anticipatingthe future: NCCC guidance on DAA treatment interruptions reliably matched AASLD Guidelinesprior to their release